LLY logo Eli Lilly and Company +
Eli Lilly and Company
+
Revenue breakdown by Products & Services
Revenue breakdown by Geography

Eli Lilly and Company's Revenue by Region

In fiscal year 2024, Eli Lilly and Company's revenue by geographical region are as follows:

  • CHINA: $1.66 B
  • Europe: $6.92 B
  • JAPAN: $1.81 B
  • Non-US: $4.27 B
  • UNITED STATES: $30.38 B

Learn more about Eli Lilly and Company’s Revenue by Products

Check out competitors to Eli Lilly and Company in a side-by-side comparison.

Explore additional financial metrics for Eli Lilly and Company.

Continue reading...

The above chart shows Eli Lilly and Company's revenue percentage share by geographical region.

In fiscal year 2022, Eli Lilly and Company's revenue by region is as follows:

  • CHINA generated $1.45 B in revenue, representing 5.09% of its total revenue.
  • Europe generated $4.30 B in revenue, representing 15.06% of its total revenue.
  • JAPAN generated $1.75 B in revenue, representing 6.12% of its total revenue.
  • Non-US generated $2.85 B in revenue, representing 9.99% of its total revenue.
  • UNITED STATES generated $18.19 B in revenue, representing 63.73% of its total revenue.

The biggest region for Eli Lilly and Company is the UNITED STATES, which represents 63.73% of its total revenue.
The smallest region for Eli Lilly and Company is the CHINA, which represents 5.09% of its total revenue.

The above chart shows Eli Lilly and Company's revenue percentage share by geographical region.

In fiscal year 2023, Eli Lilly and Company's revenue by region is as follows:

  • CHINA generated $1.54 B in revenue, representing 4.51% of its total revenue.
  • Europe generated $6.17 B in revenue, representing 18.09% of its total revenue.
  • JAPAN generated $1.67 B in revenue, representing 4.9% of its total revenue.
  • Non-US generated $2.95 B in revenue, representing 8.63% of its total revenue.
  • UNITED STATES generated $21.79 B in revenue, representing 63.86% of its total revenue.

The biggest region for Eli Lilly and Company is the UNITED STATES, which represents 63.86% of its total revenue.
The smallest region for Eli Lilly and Company is the CHINA, which represents 4.51% of its total revenue.

The above chart shows Eli Lilly and Company's revenue percentage share by geographical region.

In fiscal year 2024, Eli Lilly and Company's revenue by region is as follows:

  • CHINA generated $1.66 B in revenue, representing 3.69% of its total revenue.
  • Europe generated $6.92 B in revenue, representing 15.36% of its total revenue.
  • JAPAN generated $1.81 B in revenue, representing 4.03% of its total revenue.
  • Non-US generated $4.27 B in revenue, representing 9.48% of its total revenue.
  • UNITED STATES generated $30.38 B in revenue, representing 67.44% of its total revenue.

The biggest region for Eli Lilly and Company is the UNITED STATES, which represents 67.44% of its total revenue.
The smallest region for Eli Lilly and Company is the CHINA, which represents 3.69% of its total revenue.
Continue reading...

Summary Table

Geography (Percent Share) 2022 2023 2024
CHINA 5.09% 4.51% 3.69%
Europe 15.06% 18.09% 15.36%
JAPAN 6.12% 4.9% 4.03%
Non-US 9.99% 8.63% 9.48%
UNITED STATES 63.73% 63.86% 67.44%
Total Revenue 100% 100% 100%

The above chart shows the revenue trend of different segments of Eli Lilly and Company.

In fiscal year 2024, the UNITED STATES generated the most revenue ($30.38 B), and the CHINA generated the least revenue ($1.66 B).

The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.

  • CHINA revenue increased 7.84% ($120.70 M) from $1.54 B (in 2023) to $1.66 B (in 2024).
  • Europe revenue increased 12.08% ($746.00 M) from $6.17 B (in 2023) to $6.92 B (in 2024).
  • JAPAN revenue increased 8.51% ($142.30 M) from $1.67 B (in 2023) to $1.81 B (in 2024).
  • Non-US revenue increased 44.98% ($1.33 B) from $2.95 B (in 2023) to $4.27 B (in 2024).
  • UNITED STATES revenue increased 39.39% ($8.58 B) from $21.79 B (in 2023) to $30.38 B (in 2024).
    • Continue reading...

    Summary Table

    Region 2022
    Value Change
    		2023
    Value Change
    		2024
    Value Change
    CHINA $1.45 B - $1.54 B
    5.98%
    		$1.66 B
    7.84%
    Europe $4.30 B - $6.17 B
    43.62%
    		$6.92 B
    12.08%
    JAPAN $1.75 B - $1.67 B
    4.28%
    		$1.81 B
    8.51%
    Non-US $2.85 B - $2.95 B
    3.30%
    		$4.27 B
    44.98%
    UNITED STATES $18.19 B - $21.79 B
    19.80%
    		$30.38 B
    39.39%
    Total Revenue $28.54 B - $34.12 B
    19.56%
    		$45.04 B
    32.00%

    Frequently Asked Questions

    What was Eli Lilly and Company's largest region last year?

    In fiscal year 2024, UNITED STATES revenue reached $30.38 Billion, representing 67.44% of Eli Lilly and Company's total revenue and making it the largest region for the company.

    Which region experienced the highest growth for Eli Lilly and Company last year?

    The Non-US is Eli Lilly and Company's highest growth region, with a revenue growth of +44.98% in 2024 compared to 2023.

    Related company

    Revenue Ranking

    Revenue Ranking

    Related

    Submit feedback to Bullfincher